299
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Choroidal Thickness in Eyes with Fuchs Uveitis Syndrome

, MD, , MD, , MD & , MD
Pages 259-266 | Received 22 Nov 2014, Accepted 29 Oct 2015, Published online: 14 Jan 2016

REFERENCES

  • Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285–293.
  • Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2000;55:173–183.
  • Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16:356–363.
  • Bouchenaki N, Herbort CP. Fluorescein findings and clinical features in Fuchs’ uveitis. Int Ophthalmol. 2010;30:511–519.
  • Bouchenaki N, Herbort CP. Fuchs’ uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnostic delay. Middle East Afr J Ophthalmol. 2009;16:239–244.
  • Aziz S, Arya B, Westcott M, et al. An investigation of the disc hyperfluorescence in Fuchs uveitis syndrome using optical coherence tomography imaging. Ocul Immunol Inflamm. 2015;23:152–156.
  • Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina. 2012;32:2061–2069.
  • Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behçet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54:6033–6039.
  • Coskun E, Gurler B, Pehlivan Y, at al. Enhance Depth Imaging Optical Coherence Tomography Findings in Behçet Disease. Ocul Immunol Inflamm. 2013;21:440–445.
  • Güngör SG, Akkoyun I, Reyhan NH, et al. Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography. Ocul Immunol Inflamm. 2014;22:287–293.
  • Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.
  • Fuchs E. Über Komplicationen der Heterochomie. Z Augenheilkd. 1906;15:191–212.
  • Cimino L, Aldigeri R, Parmeggiani M, et al. Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2013; 251:1607–1612.
  • La Hey E, De Jong PT, Kijlstra A. Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol. 1994;78:307–312.
  • Velila S, Dios E, Herreras J, et al. Fuchs heterochromic iridocyclitis: a review of 26 cases. Ocul Immunol Inflamm. 2001;9:169–175.
  • Karaca EE, Özdek Ş, Yalçin NG, et al. Reproducibility of choroidal thickness measurements in healthy Turkish subjects. Eur J Ophthalmol. 2014;24:202–208.
  • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31:510–517.
  • Ishikawa S, Taguchi M, Muraoka T, et al. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet’s disease. Br J Ophthalmol. 2014;98:1508–1513.
  • Akcar N, Goktekin F, Ozer A, et al. Doppler sonography of ocular and carotid arteries in Behçet patients. J Clin Ultrasound. 2010;38:486–492.
  • Kim M, Kim SS, Kwon HJ, et al. Association between choroidal thickness and ocular perfusion pressure in young healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci. 2012;53:7710–7717.
  • Maneschg OA, Volek E, Németh J, et al. Spectral domain optical coherence tomography in patients after successful management of postoperative endophthalmitis following cataract surgery by pars plana vitrectomy. BMC Ophthalmol. 2014;14:76.
  • Fearnley IR, Rosenthal AR. Fuchs’ heterochromic iridocyclitis revisited. Acta Ophthalmol Scand. 1995;73:166–170.
  • Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, et al. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol. 2009;148:510–515.
  • Babu K, Adiga M, Govekar SR, et al. Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population. J Ophthalmic Inflamm Infect. 2013;3:14.
  • Arellanes-García L, del Carmen Preciado-Delgadillo M, Recillas-Gispert C. Fuchs’ heterochromic iridocyclitis: clinical manifestations in dark-eyed Mexican patients. Ocul Immunol Inflamm. 2002;10:125–131.
  • Yang P, Fang W, Jin H, et al. Clinical features of Chinese patients with Fuchs’ syndrome. Ophthalmology. 2006;113:473–480.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.